Month: March 2026

 Monday, March 23, 2026   Dear Shareholders and Investors, The present situation is tumultuous, leading to very strong results. The first quarter of 2026 is expected to be much better than the last quarter of 2025, which were reported February 26, 2026. The infomation below shows the excellent performance. Fixture 1) From the US Gulf via Cape Good Hope to the Far East. The TCE is USD 175,000 over 85 days.      Fixture 2) From West Africa to Asia. The TCE is USD 77,000 over 65 days. Fixture 3) A 90-day fixture. The TCE rate is USD 88,000 per day. Fixture 4) A voyage from the Baltic to Asia. The TCE is USD 150,000 over 60 days. Fixture 5) From Guyana to Europe. The TCE is USD 41,000 over 58 days. Fixture 6) From West Africa to Asia. The TCE is USD 94,000 over 54 days. Fixtures 5 & 6 were concluded before the Middle East war broke out...

HONG KONG, March 23, 2026 (GLOBE NEWSWIRE) — Skyline Builders Group Holding Limited (NASDAQ: SKBL), a Cayman Islands exempted company with limited liability (the “Company”), today announced the pricing of a brokered private placement (the “Private Placement”) of senior unsecured convertible notes of the Company (the “Notes”) and 250,000 class B preferred shares, par value $0.00001 per share, (the “Preferred Shares”) for total gross proceeds of approximately $17,175,000.00, before deducting placement agent fees and other offering expenses payable by the Company. Each Note is convertible into class A ordinary shares, par value $0.00001 per share (the “Class A Ordinary Shares”), with a conversion price of $2.40 per share, subject to certain anti-dilution adjustments, but in no event less than $1.50 per share and other customary adjustments...

Publicis enters 2026 at #1 in the US and China Despite market consolidation, Groupe will continue to lead on media billings in key markets for global clients March 23, 2026 – Paris – Publicis Groupe [Euronext Paris FR0000130577, CAC 40] Publicis once again largely outpaced competition on new business for the 7th year in a row, according to Comvergence’s New Business Barometer1, published today.  The report reveals that Publicis was #1 in 2025 global new business performance, winning c.6 times more total billings than the nearest peer, while also ranking first on global and regional net new business. In the U.S., the Groupe increased its share of billings from 36% to 42%2, confirming its leadership despite last year’s consolidation of the 3rd and 4th players. The same trend is visible in China, where Publicis’ new business means the group...

 SYDNEY, Australia, March 23, 2026 (GLOBE NEWSWIRE) — GMEX Robotics Corporation (NASDAQ: GMEX) (“GMEX Robotics” or the “Company”), a developer of AI-powered robotic technologies, announces that it has entered into a purchase agreement with a leading Australian food and beverage group (“FBG”) for the deployment of the Company’s intelligent culinary robotics systems, including its recently announced personal robotic chef – 2Fculinary AI, and the purchase order from this FBG. The AU$4.2 million agreement is with a well-established hospitality group operating multiple high-end restaurants and food service locations, including venues at major Australian airports. The purchase order covers a minimum of 50 Smart Digital Intelligence All-in-One Kitchen Robots, including the Company’s Bon Vivant 3.0 and Max models. This is the Company’s...

HIGHLIGHTSFormal centralized and independent analysis of the clinical response data from the ACCENT trial has been undertaken and updated analysis provided to the Company The data confirm that five (5) patients have achieved a complete response (CR) in the Phase 1b/2a trial of narmafotinib combined with chemotherapy resulting in an unprecedented rate of CRs of 7.8% (5/64) A median Overall Survival of 11.1 months has also been determined which is a 2 month improvement compared to chemotherapy alone, with no additional toxicity burden The Company has been chosen to present trial data at the prestigious annual meeting of the American Association of Cancer Research (AACR) being held in April 2026 in San Diego, CA, USAMelbourne, Australia, March 23, 2026 (GLOBE NEWSWIRE) — Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia”...

March 23, 2026 Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers is pleased to announce that it has entered into a strategic partnership with Tanner Pharma Group to make eRapa available for Familial Adenomatous Polyposis (FAP) patients via an Early Access Program and Named Patient prescribing. This initiative gives clinicians who treat FAP patients the opportunity to prescribe this investigational medicine outside of a clinical trial for the first time. The program will be open to clinicians globally, for appropriate patients and subject to local legislation and the availability...

LONDON, March 23, 2026 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (NYSE: NVGS) (“Navigator Gas,” the “Company,” “we,” or “our”) announced today the closing of the previously announced upsized public offering (the “Secondary Offering”) of a total of 8,000,000 shares of the Company’s common stock (the “Offered Shares”) by BW Group Limited, as the selling shareholder of the Company (the “Selling Shareholder”), at a public offering price of $17.50 per share (the “Public Offering Price”). The Company did not offer any shares of its common stock in the Secondary Offering and did not receive any proceeds from the sale of its shares of common stock in the Secondary Offering. In addition, in connection with the Company’s previously announced intention to purchase shares in the Secondary Offering, the Company purchased 3,500,000 of the Offered...